Clinical Trials Browser

Phase NA × Recurrence × Thiotepa × Clear all

NCT06385808 2024-04-26

Efficacy and Safety of MTBF Conditioning Regimen for Salvageable Allo-HSCT in the Treatment of R/R AML

Phase NA Not yet recruiting

Other hematologic neoplasm

Recurrence, Leukemia, Myeloid, Acute